IMAX CORP (IMAX)

CA45245E1097 - Common Stock

20.09  +0.69 (+3.56%)

After market: 20.09 0 (0%)

Fundamental Rating

5

Overall IMAX gets a fundamental rating of 5 out of 10. We evaluated IMAX against 73 industry peers in the Entertainment industry. IMAX has an average financial health and profitability rating. IMAX is not valued too expensively and it also shows a decent growth rate.



6

1. Profitability

1.1 Basic Checks

IMAX had positive earnings in the past year.
IMAX had a positive operating cash flow in the past year.
In the past 5 years IMAX reported 4 times negative net income.
In multiple years IMAX reported negative operating cash flow during the last 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of 3.18%, IMAX is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of 10.13%, IMAX belongs to the top of the industry, outperforming 81.94% of the companies in the same industry.
IMAX has a Return On Invested Capital of 5.61%. This is in the better half of the industry: IMAX outperforms 75.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IMAX is significantly below the industry average of 13.98%.
The 3 year average ROIC (2.38%) for IMAX is below the current ROIC(5.61%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.18%
ROE 10.13%
ROIC 5.61%
ROA(3y)-0.73%
ROA(5y)-2.27%
ROE(3y)-1.88%
ROE(5y)-6.88%
ROIC(3y)2.38%
ROIC(5y)N/A

1.3 Margins

IMAX has a Profit Margin of 7.14%. This is amongst the best in the industry. IMAX outperforms 80.56% of its industry peers.
In the last couple of years the Profit Margin of IMAX has grown nicely.
IMAX has a better Operating Margin (15.03%) than 84.72% of its industry peers.
IMAX's Operating Margin has declined in the last couple of years.
IMAX has a Gross Margin of 57.53%. This is in the better half of the industry: IMAX outperforms 69.44% of its industry peers.
In the last couple of years the Gross Margin of IMAX has remained more or less at the same level.
Industry RankSector Rank
OM 15.03%
PM (TTM) 7.14%
GM 57.54%
OM growth 3YN/A
OM growth 5Y-3.91%
PM growth 3YN/A
PM growth 5Y2.11%
GM growth 3Y53.88%
GM growth 5Y0.59%

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IMAX is destroying value.
IMAX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of 1.47, we must say that IMAX is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of IMAX (1.47) is better than 62.50% of its industry peers.
The Debt to FCF ratio of IMAX is 27.05, which is on the high side as it means it would take IMAX, 27.05 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 27.05, IMAX is in line with its industry, outperforming 59.72% of the companies in the same industry.
IMAX has a Debt/Equity ratio of 1.15. This is a high value indicating a heavy dependency on external financing.
IMAX has a worse Debt to Equity ratio (1.15) than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.15
Debt/FCF 27.05
Altman-Z 1.47
ROIC/WACC0.84
WACC6.66%

2.3 Liquidity

IMAX has a Current Ratio of 2.26. This indicates that IMAX is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of IMAX (2.26) is better than 72.22% of its industry peers.
IMAX has a Quick Ratio of 1.96. This is a normal value and indicates that IMAX is financially healthy and should not expect problems in meeting its short term obligations.
IMAX's Quick ratio of 1.96 is fine compared to the rest of the industry. IMAX outperforms 69.44% of its industry peers.
Industry RankSector Rank
Current Ratio 2.26
Quick Ratio 1.96

4

3. Growth

3.1 Past

IMAX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51.79%, which is quite impressive.
IMAX shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.04% yearly.
EPS 1Y (TTM)51.79%
EPS 3YN/A
EPS 5Y-9.04%
EPS Q2Q%-30.77%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-9.21%

3.2 Future

IMAX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 39.59% yearly.
IMAX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.78% yearly.
EPS Next Y83.81%
EPS Next 2Y46.26%
EPS Next 3Y39.59%
EPS Next 5YN/A
Revenue Next Year9.21%
Revenue Next 2Y6.64%
Revenue Next 3Y6.78%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 23.64, which indicates a rather expensive current valuation of IMAX.
Based on the Price/Earnings ratio, IMAX is valued a bit cheaper than the industry average as 77.78% of the companies are valued more expensively.
IMAX is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 24.41, which is the current average of the S&P500 Index.
IMAX is valuated correctly with a Price/Forward Earnings ratio of 16.56.
81.94% of the companies in the same industry are more expensive than IMAX, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.59, IMAX is valued at the same level.
Industry RankSector Rank
PE 23.64
Fwd PE 16.56

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IMAX indicates a somewhat cheap valuation: IMAX is cheaper than 75.00% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, IMAX is valued a bit cheaper than the industry average as 62.50% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 95.98
EV/EBITDA 10.76

4.3 Compensation for Growth

IMAX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IMAX has a very decent profitability rating, which may justify a higher PE ratio.
IMAX's earnings are expected to grow with 39.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.28
PEG (5Y)N/A
EPS Next 2Y46.26%
EPS Next 3Y39.59%

0

5. Dividend

5.1 Amount

IMAX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

IMAX CORP

NYSE:IMAX (7/26/2024, 7:04:00 PM)

After market: 20.09 0 (0%)

20.09

+0.69 (+3.56%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.06B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 23.64
Fwd PE 16.56
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.28
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.18%
ROE 10.13%
ROCE
ROIC
ROICexc
ROICexgc
OM 15.03%
PM (TTM) 7.14%
GM 57.54%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 1.15
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.26
Quick Ratio 1.96
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)51.79%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y83.81%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y